Structure

Physi-Chem Properties

Molecular Weight:  648.33
Volume:  675.769
LogP:  7.34
LogD:  3.171
LogS:  -3.165
# Rotatable Bonds:  10
TPSA:  150.59
# H-Bond Aceptor:  9
# H-Bond Donor:  4
# Rings:  6
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.218
Synthetic Accessibility Score:  7.018
Fsp3:  0.553
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.315
MDCK Permeability:  1.3086390026728623e-05
Pgp-inhibitor:  0.4
Pgp-substrate:  0.986
Human Intestinal Absorption (HIA):  0.702
20% Bioavailability (F20%):  0.087
30% Bioavailability (F30%):  0.019

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.052
Plasma Protein Binding (PPB):  93.8689193725586%
Volume Distribution (VD):  0.983
Pgp-substrate:  6.775910377502441%

ADMET: Metabolism

CYP1A2-inhibitor:  0.018
CYP1A2-substrate:  0.105
CYP2C19-inhibitor:  0.015
CYP2C19-substrate:  0.455
CYP2C9-inhibitor:  0.065
CYP2C9-substrate:  0.917
CYP2D6-inhibitor:  0.015
CYP2D6-substrate:  0.099
CYP3A4-inhibitor:  0.201
CYP3A4-substrate:  0.101

ADMET: Excretion

Clearance (CL):  1.718
Half-life (T1/2):  0.019

ADMET: Toxicity

hERG Blockers:  0.011
Human Hepatotoxicity (H-HT):  0.961
Drug-inuced Liver Injury (DILI):  0.956
AMES Toxicity:  0.004
Rat Oral Acute Toxicity:  0.97
Maximum Recommended Daily Dose:  0.126
Skin Sensitization:  0.138
Carcinogencity:  0.343
Eye Corrosion:  0.003
Eye Irritation:  0.009
Respiratory Toxicity:  0.97

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC476311

Natural Product ID:  NPC476311
Common Name*:   QYRPARUSUFWOPG-HBWLMKOJSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  QYRPARUSUFWOPG-HBWLMKOJSA-N
Standard InCHI:  InChI=1S/C38H48O9/c1-19(2)10-9-11-21(5)13-15-23-29(39)24(14-12-20(3)4)33-27(30(23)40)32(42)28-31(41)25-18-26-36(7,8)47-37(34(25)43,38(26,28)46-33)17-16-22(6)35(44)45/h10,12-13,16,25-26,28,31,39-41H,9,11,14-15,17-18H2,1-8H3,(H,44,45)/b21-13+,22-16-/t25-,26-,28?,31?,37-,38-/m0/s1
SMILES:  CC(=CCCC(=CCC1=C(C(=C2C(=C1O)C(=O)C3C(C4CC5C3(O2)C(C4=O)(OC5(C)C)CC=C(C)C(=O)O)O)CC=C(C)C)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL563615
PubChem CID:   45272280
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. latex n.a. PMID[17117343]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. fruit n.a. PMID[17117343]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota resin n.a. n.a. PMID[19072548]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. n.a. n.a. PMID[21486005]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO13310 Garcinia hanburyi Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT165 Cell Line HeLa Homo sapiens IC50 = 5080.0 nM PMID[517934]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC476311 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9817 High Similarity NPC476210
0.9817 High Similarity NPC476199
0.9758 High Similarity NPC473729
0.9639 High Similarity NPC473607
0.9576 High Similarity NPC162248
0.9515 High Similarity NPC476139
0.9515 High Similarity NPC476152
0.9512 High Similarity NPC476196
0.9461 High Similarity NPC233978
0.9451 High Similarity NPC41598
0.9401 High Similarity NPC227275
0.9398 High Similarity NPC476229
0.9387 High Similarity NPC189689
0.9337 High Similarity NPC476159
0.9333 High Similarity NPC158329
0.9333 High Similarity NPC476146
0.9333 High Similarity NPC40089
0.9333 High Similarity NPC476216
0.9333 High Similarity NPC102810
0.9286 High Similarity NPC98943
0.9222 High Similarity NPC169018
0.9222 High Similarity NPC118128
0.9217 High Similarity NPC63514
0.9217 High Similarity NPC47634
0.9217 High Similarity NPC55422
0.9217 High Similarity NPC75141
0.9157 High Similarity NPC223413
0.9141 High Similarity NPC286422
0.9112 High Similarity NPC475398
0.9096 High Similarity NPC476255
0.9096 High Similarity NPC62444
0.9012 High Similarity NPC208069
0.8976 High Similarity NPC131578
0.8941 High Similarity NPC475080
0.8916 High Similarity NPC94796
0.8862 High Similarity NPC476931
0.8851 High Similarity NPC475656
0.8851 High Similarity NPC475148
0.8817 High Similarity NPC193222
0.881 High Similarity NPC473908
0.8795 High Similarity NPC43490
0.8795 High Similarity NPC475107
0.8772 High Similarity NPC477529
0.8757 High Similarity NPC476056
0.8743 High Similarity NPC476929
0.8728 High Similarity NPC469345
0.8727 High Similarity NPC164427
0.8721 High Similarity NPC469393
0.8713 High Similarity NPC193698
0.8683 High Similarity NPC472055
0.8675 High Similarity NPC476930
0.8671 High Similarity NPC232412
0.8671 High Similarity NPC98667
0.8671 High Similarity NPC86809
0.8671 High Similarity NPC294149
0.8663 High Similarity NPC473113
0.8655 High Similarity NPC54903
0.8655 High Similarity NPC473095
0.8655 High Similarity NPC286074
0.8655 High Similarity NPC473096
0.865 High Similarity NPC476509
0.8647 High Similarity NPC475109
0.8636 High Similarity NPC182693
0.8631 High Similarity NPC92589
0.8623 High Similarity NPC470339
0.8621 High Similarity NPC312630
0.8621 High Similarity NPC324220
0.8619 High Similarity NPC470195
0.8619 High Similarity NPC316274
0.8619 High Similarity NPC470196
0.8619 High Similarity NPC470193
0.8619 High Similarity NPC470200
0.8619 High Similarity NPC470194
0.8619 High Similarity NPC470197
0.8619 High Similarity NPC282474
0.8619 High Similarity NPC470198
0.8614 High Similarity NPC477674
0.8605 High Similarity NPC241387
0.8605 High Similarity NPC313717
0.8605 High Similarity NPC315306
0.8605 High Similarity NPC251144
0.8603 High Similarity NPC314672
0.8598 High Similarity NPC476162
0.8596 High Similarity NPC472622
0.8596 High Similarity NPC473094
0.8588 High Similarity NPC106700
0.8588 High Similarity NPC472049
0.858 High Similarity NPC475106
0.8571 High Similarity NPC477682
0.8571 High Similarity NPC477683
0.8563 High Similarity NPC474345
0.8555 High Similarity NPC121333
0.8555 High Similarity NPC472620
0.8554 High Similarity NPC477671
0.8554 High Similarity NPC477687
0.8547 High Similarity NPC297195
0.8547 High Similarity NPC207574
0.8547 High Similarity NPC291795
0.8538 High Similarity NPC120857
0.8538 High Similarity NPC13481
0.8538 High Similarity NPC85047
0.8538 High Similarity NPC207575
0.8538 High Similarity NPC17274
0.8538 High Similarity NPC469394
0.8538 High Similarity NPC472621
0.8537 High Similarity NPC321387
0.8537 High Similarity NPC327059
0.8537 High Similarity NPC470908
0.8531 High Similarity NPC313452
0.8528 High Similarity NPC472345
0.8523 High Similarity NPC244903
0.8521 High Similarity NPC117985
0.8521 High Similarity NPC472346
0.8514 High Similarity NPC478050
0.8514 High Similarity NPC475233
0.8512 High Similarity NPC125969
0.8508 High Similarity NPC470199
0.8508 High Similarity NPC314459
0.8506 High Similarity NPC472054
0.8506 High Similarity NPC17105
0.8506 High Similarity NPC474276
0.8506 High Similarity NPC147363
0.8506 High Similarity NPC73899
0.8503 High Similarity NPC20530
0.8503 High Similarity NPC10754
0.8503 High Similarity NPC215917
0.8503 High Similarity NPC474386
0.85 High Similarity NPC295436
0.8497 Intermediate Similarity NPC279209
0.8497 Intermediate Similarity NPC102277
0.8497 Intermediate Similarity NPC477670
0.8494 Intermediate Similarity NPC477669
0.8492 Intermediate Similarity NPC282636
0.8492 Intermediate Similarity NPC294863
0.8488 Intermediate Similarity NPC150131
0.8488 Intermediate Similarity NPC76647
0.848 Intermediate Similarity NPC316262
0.848 Intermediate Similarity NPC314653
0.8475 Intermediate Similarity NPC315221
0.8466 Intermediate Similarity NPC5671
0.8462 Intermediate Similarity NPC470810
0.8462 Intermediate Similarity NPC306978
0.8462 Intermediate Similarity NPC314020
0.8462 Intermediate Similarity NPC243701
0.8457 Intermediate Similarity NPC68381
0.8443 Intermediate Similarity NPC68727
0.8443 Intermediate Similarity NPC175192
0.8439 Intermediate Similarity NPC472619
0.8439 Intermediate Similarity NPC217378
0.8439 Intermediate Similarity NPC242395
0.8439 Intermediate Similarity NPC152477
0.8439 Intermediate Similarity NPC20734
0.8436 Intermediate Similarity NPC197972
0.8434 Intermediate Similarity NPC256141
0.843 Intermediate Similarity NPC125465
0.843 Intermediate Similarity NPC128293
0.843 Intermediate Similarity NPC82330
0.8427 Intermediate Similarity NPC150977
0.8424 Intermediate Similarity NPC180351
0.8421 Intermediate Similarity NPC473009
0.8421 Intermediate Similarity NPC273959
0.8421 Intermediate Similarity NPC472581
0.8421 Intermediate Similarity NPC474240
0.8421 Intermediate Similarity NPC469395
0.8418 Intermediate Similarity NPC473785
0.8412 Intermediate Similarity NPC97812
0.8412 Intermediate Similarity NPC3629
0.8405 Intermediate Similarity NPC470910
0.8402 Intermediate Similarity NPC239118
0.8402 Intermediate Similarity NPC4950
0.84 Intermediate Similarity NPC476374
0.84 Intermediate Similarity NPC471969
0.84 Intermediate Similarity NPC98776
0.8395 Intermediate Similarity NPC18886
0.8393 Intermediate Similarity NPC477675
0.8393 Intermediate Similarity NPC321372
0.8393 Intermediate Similarity NPC474609
0.8393 Intermediate Similarity NPC109967
0.8393 Intermediate Similarity NPC78554
0.8393 Intermediate Similarity NPC129053
0.8393 Intermediate Similarity NPC475797
0.8393 Intermediate Similarity NPC471787
0.8393 Intermediate Similarity NPC469936
0.8393 Intermediate Similarity NPC474738
0.8391 Intermediate Similarity NPC298778
0.8391 Intermediate Similarity NPC241874
0.8389 Intermediate Similarity NPC174486
0.8383 Intermediate Similarity NPC180301
0.8383 Intermediate Similarity NPC293286
0.8383 Intermediate Similarity NPC301233
0.8383 Intermediate Similarity NPC209760
0.8383 Intermediate Similarity NPC236756
0.8383 Intermediate Similarity NPC469405
0.8383 Intermediate Similarity NPC311579
0.8383 Intermediate Similarity NPC248793
0.8383 Intermediate Similarity NPC471695
0.8383 Intermediate Similarity NPC100134
0.8382 Intermediate Similarity NPC476459
0.8382 Intermediate Similarity NPC470456
0.8382 Intermediate Similarity NPC292233

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476311 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8563 High Similarity NPD7075 Discontinued
0.8443 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8383 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8287 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8274 Intermediate Similarity NPD7819 Suspended
0.8263 Intermediate Similarity NPD7411 Suspended
0.8232 Intermediate Similarity NPD2532 Approved
0.8232 Intermediate Similarity NPD2533 Approved
0.8232 Intermediate Similarity NPD2534 Approved
0.8229 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD6801 Discontinued
0.8167 Intermediate Similarity NPD8434 Phase 2
0.8161 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.814 Intermediate Similarity NPD5494 Approved
0.8125 Intermediate Similarity NPD5844 Phase 1
0.8114 Intermediate Similarity NPD7473 Discontinued
0.8095 Intermediate Similarity NPD4380 Phase 2
0.807 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8057 Intermediate Similarity NPD6166 Phase 2
0.8057 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8057 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8045 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8034 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD5402 Approved
0.8011 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD6959 Discontinued
0.7967 Intermediate Similarity NPD8150 Discontinued
0.7965 Intermediate Similarity NPD3882 Suspended
0.7953 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7944 Intermediate Similarity NPD7808 Phase 3
0.7943 Intermediate Similarity NPD6232 Discontinued
0.7919 Intermediate Similarity NPD3749 Approved
0.7919 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7907 Intermediate Similarity NPD3817 Phase 2
0.7904 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7904 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7889 Intermediate Similarity NPD6559 Discontinued
0.7889 Intermediate Similarity NPD7251 Discontinued
0.7882 Intermediate Similarity NPD6599 Discontinued
0.7865 Intermediate Similarity NPD3818 Discontinued
0.7861 Intermediate Similarity NPD7768 Phase 2
0.7844 Intermediate Similarity NPD6799 Approved
0.7833 Intermediate Similarity NPD6797 Phase 2
0.7818 Intermediate Similarity NPD2800 Approved
0.7811 Intermediate Similarity NPD5403 Approved
0.7802 Intermediate Similarity NPD8313 Approved
0.7802 Intermediate Similarity NPD8312 Approved
0.7791 Intermediate Similarity NPD1934 Approved
0.7778 Intermediate Similarity NPD7074 Phase 3
0.7771 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.776 Intermediate Similarity NPD7435 Discontinued
0.774 Intermediate Similarity NPD5710 Approved
0.774 Intermediate Similarity NPD5711 Approved
0.7722 Intermediate Similarity NPD7054 Approved
0.7719 Intermediate Similarity NPD3226 Approved
0.7692 Intermediate Similarity NPD5401 Approved
0.7684 Intermediate Similarity NPD1247 Approved
0.768 Intermediate Similarity NPD7472 Approved
0.7667 Intermediate Similarity NPD3751 Discontinued
0.7651 Intermediate Similarity NPD1549 Phase 2
0.7644 Intermediate Similarity NPD2801 Approved
0.7632 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7614 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7614 Intermediate Similarity NPD7874 Approved
0.7605 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7594 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD37 Approved
0.7577 Intermediate Similarity NPD7697 Approved
0.7577 Intermediate Similarity NPD7698 Approved
0.7577 Intermediate Similarity NPD7696 Phase 3
0.7571 Intermediate Similarity NPD919 Approved
0.7569 Intermediate Similarity NPD7228 Approved
0.7563 Intermediate Similarity NPD8151 Discontinued
0.7557 Intermediate Similarity NPD4967 Phase 2
0.7557 Intermediate Similarity NPD4965 Approved
0.7557 Intermediate Similarity NPD4966 Approved
0.7545 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD1465 Phase 2
0.7542 Intermediate Similarity NPD3787 Discontinued
0.7538 Intermediate Similarity NPD7871 Phase 2
0.7538 Intermediate Similarity NPD7870 Phase 2
0.7513 Intermediate Similarity NPD6782 Approved
0.7513 Intermediate Similarity NPD6777 Approved
0.7513 Intermediate Similarity NPD6779 Approved
0.7513 Intermediate Similarity NPD6778 Approved
0.7513 Intermediate Similarity NPD6776 Approved
0.7513 Intermediate Similarity NPD6780 Approved
0.7513 Intermediate Similarity NPD6781 Approved
0.7472 Intermediate Similarity NPD6234 Discontinued
0.7456 Intermediate Similarity NPD3750 Approved
0.7456 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD6651 Approved
0.7449 Intermediate Similarity NPD8320 Phase 1
0.7449 Intermediate Similarity NPD8319 Approved
0.7442 Intermediate Similarity NPD1512 Approved
0.7425 Intermediate Similarity NPD2796 Approved
0.7424 Intermediate Similarity NPD7701 Phase 2
0.7409 Intermediate Similarity NPD7699 Phase 2
0.7409 Intermediate Similarity NPD7700 Phase 2
0.7403 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD7783 Phase 2
0.74 Intermediate Similarity NPD7801 Approved
0.7399 Intermediate Similarity NPD920 Approved
0.7394 Intermediate Similarity NPD5124 Phase 1
0.7394 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD2346 Discontinued
0.7365 Intermediate Similarity NPD1510 Phase 2
0.7363 Intermediate Similarity NPD2403 Approved
0.7353 Intermediate Similarity NPD4628 Phase 3
0.7344 Intermediate Similarity NPD6534 Approved
0.7344 Intermediate Similarity NPD6535 Approved
0.733 Intermediate Similarity NPD8366 Approved
0.7326 Intermediate Similarity NPD1511 Approved
0.7321 Intermediate Similarity NPD6099 Approved
0.7321 Intermediate Similarity NPD2935 Discontinued
0.7321 Intermediate Similarity NPD6100 Approved
0.7314 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD6190 Approved
0.7308 Intermediate Similarity NPD3926 Phase 2
0.7294 Intermediate Similarity NPD1243 Approved
0.7293 Intermediate Similarity NPD8127 Discontinued
0.7293 Intermediate Similarity NPD7199 Phase 2
0.7283 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD8285 Discontinued
0.7262 Intermediate Similarity NPD2799 Discontinued
0.7258 Intermediate Similarity NPD5953 Discontinued
0.7253 Intermediate Similarity NPD7229 Phase 3
0.7247 Intermediate Similarity NPD5760 Phase 2
0.7247 Intermediate Similarity NPD5761 Phase 2
0.7246 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD1607 Approved
0.7245 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7243 Intermediate Similarity NPD7286 Phase 2
0.7229 Intermediate Similarity NPD1240 Approved
0.7219 Intermediate Similarity NPD7240 Approved
0.7219 Intermediate Similarity NPD1551 Phase 2
0.7219 Intermediate Similarity NPD7685 Pre-registration
0.7216 Intermediate Similarity NPD7458 Discontinued
0.72 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD8491 Approved
0.7189 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD7799 Discontinued
0.7181 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD6823 Phase 2
0.7168 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD3748 Approved
0.7156 Intermediate Similarity NPD8469 Approved
0.7151 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD8455 Phase 2
0.7135 Intermediate Similarity NPD4287 Approved
0.7128 Intermediate Similarity NPD6764 Approved
0.7128 Intermediate Similarity NPD6765 Approved
0.7126 Intermediate Similarity NPD7390 Discontinued
0.7108 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD2313 Discontinued
0.7108 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD8407 Phase 2
0.7083 Intermediate Similarity NPD6355 Discontinued
0.7081 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD1471 Phase 3
0.7069 Intermediate Similarity NPD7236 Approved
0.7053 Intermediate Similarity NPD8404 Phase 2
0.7052 Intermediate Similarity NPD7982 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD6273 Approved
0.7039 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD8368 Discontinued
0.703 Intermediate Similarity NPD7584 Approved
0.7006 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7907 Approved
0.6994 Remote Similarity NPD6674 Discontinued
0.699 Remote Similarity NPD4363 Phase 3
0.699 Remote Similarity NPD4360 Phase 2
0.6982 Remote Similarity NPD230 Phase 1
0.6979 Remote Similarity NPD6785 Approved
0.6979 Remote Similarity NPD6784 Approved
0.6977 Remote Similarity NPD2344 Approved
0.6977 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6977 Remote Similarity NPD8067 Phase 3
0.6966 Remote Similarity NPD7239 Suspended
0.6959 Remote Similarity NPD8435 Approved
0.6959 Remote Similarity NPD8361 Approved
0.6959 Remote Similarity NPD7033 Discontinued
0.6959 Remote Similarity NPD8360 Approved
0.6923 Remote Similarity NPD4060 Phase 1
0.6923 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6919 Remote Similarity NPD5406 Approved
0.6919 Remote Similarity NPD5408 Approved
0.6919 Remote Similarity NPD5405 Approved
0.6919 Remote Similarity NPD5404 Approved
0.6905 Remote Similarity NPD3764 Approved
0.6905 Remote Similarity NPD6798 Discontinued
0.6905 Remote Similarity NPD7985 Registered
0.6905 Remote Similarity NPD3268 Approved
0.6901 Remote Similarity NPD7097 Phase 1
0.6897 Remote Similarity NPD7211 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data